XML 75 R39.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting (Tables)
9 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Schedule of segment financial information
     Three months Ended March 31,      Nine months Ended March 31,  
    2020     2019     2020     2019  
 Consolidated revenue:                        
Aytu BioScience   $ 4,703,000     $ 2,378,000     $ 9,318,000     $ 5,605,000  
Aytu Consumer Health     3,453,000               3,453,000          
Consolidated revenue     8,156,000       2,378,000       12,771,000       5,605,000  
                                 
                                 
Consolidated net loss:                                
Aytu BioScience     (4,421,000 )     (4,496,000 )     (9,565,000 )     (12,600,000 )
Aytu Consumer Health     (911,000 )             (911,000 )        
Consolidated net loss     (5,332,000 )     (4,496,000 )     (10,476,000 )     (12,600,000 )

 

     March 31, 2020      June 30, 2019  
Total assets:                
Aytu BioScience   137,825,000     34,721,000  
Aytu Consumer Health     21,129,000        -  
Total assets   $ 158,954,000     $ 34,721,000